MM&M19h
Sticking with it: Syringe designer Marc Koska is a case study in tenacity
Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...
Tuberculosis is on the rise again. We can fight it — if we try
Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of ...